50% of patients with rheumatoid arthritis are misdiagnosed and mistreated, and multiple drugs can help achieve standard treatment

Swelling and pain, morning stiffness, joint deformities, lifelong use.

Professor Gu Jieruo, director of the Department of Rheumatology and Immunology of the Third Affiliated Hospital of Sun Yat-sen University, said that 50% of patients with rheumatoid arthritis are clinically misdiagnosed and mistreated.

It is reported that as a chronic disease, rheumatoid arthritis requires long-term treatment, and new drugs and good drugs are facing the situation of expensive and unaffordable.

Rheumatoid arthritis has a high disability rate, and early treatment is critical

Rheumatoid arthritis is a chronic, inflammatory, and systemic autoimmune system disease.

According to statistics, the prevalence rate of rheumatoid arthritis in my country is 0.

Clinically, rheumatoid arthritis mainly manifests as symmetrical, chronic, and progressive polyarthritis, which is characterized by pain, swelling and morning stiffness in the hands, wrists, elbows, ankles and foot joints, and may be accompanied by symptoms such as fever and fatigue ; And as the disease progresses, when cartilage and bone are involved, it is easy to cause the destruction of articular cartilage, bone and joint capsule, and eventually lead to joint deformity and even loss of function.

"The etiology and pathogenesis of rheumatoid arthritis are relatively complex, and are closely related to factors such as genetics, environment, sex hormones, and neuropsychiatric status.

Standardize rheumatoid arthritis treatment, new drugs bring good news to patients

It is understood that the treatment goal of rheumatoid arthritis is to achieve disease remission or low disease activity, that is, to achieve standard treatment.

In recent years, with the in-depth research on rheumatoid arthritis and therapeutic drugs, the emergence of JAK inhibitors has brought new treatment options for the majority of patients, and has been unanimously recommended by domestic and foreign guidelines.

"Compared with other types of drugs, about 90% of patients can achieve effective pain relief within half a year.